Luxottica Group Q2 2014 Results Show Continuing Growth in North America, Emerging Markets and Europe

By Staff
Friday, July 25, 2014 12:26 AM
MILAN— Luxottica Group (NYSE: LUX) reported accelerated net sales growth in the second quarter ending June 30, 2014 to €2,060 million, up 7 percent at constant exchange rates when compared to the €2,018 million generated during the same period of 2013, according to the company’s financial results released yesterday.

Allergan Sales Rose Nearly 16 Percent in Second Quarter

By Staff
Wednesday, July 23, 2014 12:26 AM IRVINE, Calif.— Allergan (NYSE: AGN) reported $1,827.3 million total product net sales for the quarter ended June 30, 2014, a 15.9 percent compared to total product net sales in the second quarter of 2013.

MacKeyser/American Optical Services Makes Second Bankruptcy Court Appearance, Schedules Auction of Certain Assets

By Staff
Monday, July 21, 2014 12:36 AM WILMINGTON, Del.—The Chapter 11 bankruptcy proceedings for MacKeyser Holdings, LLC and its subsidiaries, which include American Optical Services (AOS) and a number of other optical businesses the company had acquired prior to its bankruptcy, proceeded last week with the company’s second court appearance on July 16.

Allergan Announces Q2 Conference Call

By Staff
Monday, July 21, 2014 12:24 AM IRVINE, Calif.— Allergan, Inc. (NYSE: AGN) will host a conference call to discuss the company’s second quarter 2014 results today beginning at 7:30 a.m. Pacific Time (10:30 am Eastern Time) with David Pyott, chairman and CEO, and Jeff Edwards, executive vice president, finance and business development and chief financial officer.

New Customers Drive Optos Sales Growth in 2014 Fiscal Year Third Quarter

By Staff
Friday, July 18, 2014 12:24 AM LONDON—Retinal imaging company, Optos PLC (LSE: OPTS) announced yesterday that its revenues for the company’s third quarter (the three-month period ending June 30, 2014) of the company’s 2014 fiscal year were $42 million, 5 percent higher than the $40.1 million generated during the comparable period last year.

Allergan Files Investor Presentation Claiming Valeant’s Business Model is 'Unsustainable'

By Staff
Wednesday, July 16, 2014 12:27 AM IRVINE, Calif.— Allergan, Inc. (NYSE: AGN) has filed an investor presentation with the Securities and Exchange Commission that raises further concerns about what it characterizes as “potential business risks and issues” related to a proposed purchase by Valeant Pharmaceuticals International (NYSE/TSX: VRX).

Johnson & Johnson Vision Care Second Quarter U.S. Sales Flat

By Staff
Wednesday, July 16, 2014 12:14 AM NEW BRUNSWICK, N.J.—U.S. sales for the vision care division of Johnson & Johnson (NYSE: JNJ) remained flat at $262 million for the second quarter of 2014 when compared with an equal amount of sales for the same period for 2013, according to the 2014 second quarter financial results released yesterday by the company.

Allergan, Ackman Agree Special Meeting Won't Trigger Poison Pill, Reuters Reports

By Staff
Monday, June 30, 2014 12:26 AM IRVINE, Calif.—Reuters reported Pershing Square Capital Management, led by activist investor William Ackman, and Allergan Inc. have agreed that calling a special meeting in an effort to elect new board members will not trigger Allergan's so-called "poison pill" measure, settling a lawsuit, the companies said on Friday.

Hedge Fund Paulson & Co. Amasses Large Stake in Allergan, Reuters Reports

By Staff
Friday, June 27, 2014 12:26 AM IRVINE, Calif.—Reuters reported Wednesday that hedge fund Paulson & Co has amassed more than 6 million shares of Allergan (NYSE: AGN) stock and supports a deal between Allergan and Valeant Pharmaceuticals (NYSE/TSX: VRX), people familiar with the matter told Reuters.

Grenville Completes Follow-On Investment in PFO Global Group

By Staff
Monday, June 23, 2014 12:26 AM TORONTO— Grenville Strategic Royalty Corp. (TSX VENTURE:GRC), based here, has advanced an additional $500,000 to Pro Fit Optix Holding Company, doing business as PFO Global Group.

Valeant Presses Bid for Allergan with Exchange Offer to Stockholders

By Staff
Friday, June 20, 2014 12:30 AM LAVAL, Quebec— Valeant Pharmaceuticals International (NYSE: VRX), based here, stepped up its bid to acquire Botox-maker Allergan (NYSE: AGN) by announcing Wednesday that it is taking its latest proposal directly to Allergan stockholders.

Online Optical Retailer, Iristocracy.com Receives $250,000 Loan From Wisconsin Economic Development Corporation

By Staff
Wednesday, June 18, 2014 12:26 AM MADISON, Wis.—Online eyewear and accessories retailer, Iristocracy.com received a $250,000 loan from the Wisconsin Economic Development Corporation (WEDC).

Allergan Board Unanimously Rejects Revised Unsolicited Proposal From Valeant

By Staff
Wednesday, June 11, 2014 12:29 AM IRVINE, Calif.— Allergan, Inc. (NYSE:AGN) announced yesterday that its board of directors, after consulting with its independent financial and legal advisors, has unanimously determined that the revised unsolicited proposal dated May 30, 2014 by Pershing Square Capital Management, L.P. and Valeant Pharmaceuticals International, Inc. “substantially undervalues the company, creates significant risks and uncertainties for the stockholders of Allergan, and is not in the best interests of the company and its stockholders.”

The Cooper Companies Announces Second Quarter 2014 Results

By Staff
Wednesday, June 11, 2014 12:26 AM PLEASANTON, Calif.—The Cooper Companies, Inc. (NYSE:COO) announced financial results for the fiscal second quarter ended April 30, 2014.

Vuzix Announces $3 Million in Financing Private Placement

By Staff
Friday, June 06, 2014 12:23 AM ROCHESTER, N.Y.— Vuzix Corporation (OTC:QB: VUZI) has entered into a definitive agreement with institutional investors for the sale of $3 million in aggregate principal amount of 5 percent Senior Secured Convertible Notes due June 2, 2017.
Loading...